U.S. Healthtech Stock News

NasdaqGS:GEMI
NasdaqGS:GEMICapital Markets

Assessing Gemini Space Station (GEMI) Valuation After Improved Quarterly Earnings And Ongoing Share Price Weakness

Gemini Space Station (GEMI) is back in focus after reporting first quarter 2026 earnings, with sales of US$48.58 million, revenue of US$50.27 million and a net loss of US$108.98 million, all compared with the prior year period. See our latest analysis for Gemini Space Station. Gemini Space Station’s share price has climbed over the past month, with a 30 day share price return of 15.29% and a 7 day gain of 11.60%. However, year to date the share price return is still down 46.14%, suggesting...
NasdaqCM:MARA
NasdaqCM:MARASoftware

MARA Holdings Pivot To Energy Backed AI Draws New Investor Attention

MARA Holdings has advanced its planned $1.5b acquisition of Long Ridge Energy & Power by securing key bondholder approvals. The deal is intended to shift the company’s focus from Bitcoin mining toward energy backed AI compute and digital infrastructure. Former President Donald Trump has invested in MARA shares, drawing fresh attention to the NasdaqCM:MARA story. At a share price of $12.44, NasdaqCM:MARA has seen mixed performance, with the stock up 18.8% over the past 30 days and 25.5%...
NasdaqCM:ABAT
NasdaqCM:ABATMetals and Mining

Assessing American Battery Technology (ABAT) Valuation After Strong Q3 Results And First Positive Gross Margin

American Battery Technology (ABAT) is in focus after its fiscal Q3 2026 earnings, where the company reported a 64% quarter over quarter revenue increase to US$7.8 million and its first positive gross margin. See our latest analysis for American Battery Technology. Despite the strong Q3 revenue update and first positive gross margin, the share price has eased recently, with the 90 day share price return down 17.63% while the 1 year total shareholder return is roughly double. If this kind of...
NYSE:BRBR
NYSE:BRBRPersonal Products

BellRing Brands Faces Margin Pressure Yet Screens As Deep Value Opportunity

BellRing Brands (NYSE:BRBR) reported a weaker quarter, with margin pressure and a rare pullback in household spending on its core ready to drink shakes. Management highlighted heavier promotions, rising freight costs, and consumers shifting toward value focused options as key headwinds. These pressures led the company to revise revenue guidance downward, signaling a change in demand patterns for its products. For investors watching NYSE:BRBR, the latest update comes after a steep share...
NYSE:UWMC
NYSE:UWMCDiversified Financial

UWM Bid For Two Harbors Tests Growth Ambitions And Deal Risks

UWM Holdings (NYSE:UWMC) has submitted an unsolicited proposal to acquire Two Harbors Investment Corp. The company is urging Two Harbors shareholders to reject a separate merger agreement with CrossCountry Mortgage. UWM Holdings has publicly criticized the Two Harbors board for supporting the CrossCountry deal instead of engaging with its offer. UWM Holdings operates in the U.S. mortgage market, where scale, access to capital, and distribution reach can be important for long term...
NYSE:KODK
NYSE:KODKTech

Is Kodak’s (KODK) Connected Family Push a Smart Brand Extension or a Strategic Distraction?

Earlier in May 2026, Hubble Connected announced a new line of Kodak-licensed connected family technology products, spanning smart nursery, pet monitoring and feeding devices, and children’s communication wearables, all managed via the KodakHubbleClub app and showcased at the ABC Kids Expo in Las Vegas. This collaboration shifts Kodak’s brand further into everyday connected family ecosystems, linking its imaging heritage with Hubble Connected’s platform to extend the Kodak name beyond...
NYSE:IRT
NYSE:IRTResidential REITs

Independence Realty Trust Lifts Dividend As Valuation And Coverage Questions Linger

Independence Realty Trust (NYSE:IRT) has announced an increase in its quarterly dividend. The new dividend level was approved by the board of directors and reflects an updated capital allocation decision. The change in dividend policy comes as the company continues to focus on its multifamily real estate portfolio. Independence Realty Trust focuses on owning and operating multifamily apartment communities, a segment that often reacts closely to rental demand, occupancy trends, and financing...
NYSE:INVH
NYSE:INVHResidential REITs

Is Invitation Homes (INVH) Pricing Fairly After Recent Share Price Weakness And DCF Upside?

With Invitation Homes on many watchlists, the key question for you is whether the current share price reflects the underlying value of its single family rental portfolio or if the stock is pricing in too much caution. Recent returns are mixed, with the share price down 2.8% over the last week, up 6.3% over the last month, and only slightly positive at 0.8% year to date, while the 1 year return shows a decline of 15.4% from the previous level. Over the past few months, headlines around U.S...
NasdaqGS:PLAB
NasdaqGS:PLABSemiconductor

Photronics Finance Appointment Tests Growth Story And Valuation Discipline

Photronics, NasdaqGS:PLAB, has appointed Christopher Dayton as Senior Vice President, Finance. Dayton will oversee global financial strategy and support the company’s long term growth plans. Photronics, trading at $50.02, has been on a strong run, with the stock up 49.7% year to date and 143.4% over the past year. Over a 3 year period the stock is up 188.0%, and over 5 years it is up 272.7%, which puts recent performance firmly on investors’ radar. The share price has pulled back 6.7% over...
NasdaqGM:HROW
NasdaqGM:HROWPharmaceuticals

Harrow’s TRIESENCE Phase 3 Milestone Adds New Dimension To Growth Story

Harrow received FDA clearance of its Investigational New Drug application for TRIESENCE, allowing a Phase 3 clinical trial to proceed. This regulatory decision marks a key clinical milestone for the company’s ophthalmic drug pipeline. The TRIESENCE Phase 3 program adds a new pillar to Harrow's story beyond previously discussed earnings and financial guidance. Harrow, trading on NasdaqGM:HROW, now has a fresh clinical catalyst in play alongside its existing commercial portfolio. The stock...